-4.3%
FSLY vs THC
+413.3%
-417.6%
-80.0%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +3.1% | -1.1% | +4.1% | +3.3% |
| 7D | -31.4% | +3.7% | -35.1% | -31.8% |
| 30D | -37.3% | +9.0% | -46.3% | -38.4% |
| 3M | -30.1% | +10.4% | -40.5% | -31.7% |
| 6M | -49.8% | +45.7% | -95.5% | -54.1% |
| YTD | +55.7% | +42.6% | +13.1% | +43.0% |
| 1Y | +44.5% | +38.8% | +5.7% | +33.3% |
| 3Y | -4.3% | +418.8% | -423.2% | -63.2% |
| All | -4.3% | +413.3% | -417.6% | -63.2% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling